VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Avadel Pharmaceuticals plc (AVDL) Total Return Calculator with Dividends Reinvested

Avadel Pharmaceuticals plc

Popular:

The total return for Avadel Pharmaceuticals plc (AVDL) stock is +150.46% over the past 12 months. So far it's up 0.56% this year. The 5-year total return is +174.62%, meaning $10,000 invested in AVDL stock 5 years ago would be worth $27,462 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in AVDL 1 year ago, it would be worth $22,851 today — you'd have gained $12,851.

With Dividends Reinvested$22,851+128.51%

Price Only (No DRIP)$22,851+128.51%

Period2025-05-07 → 2026-02-13

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in AVDL

1Y$25,046+$15,046 (+150.5%)150.5% CAGR

3Y$14,582+$4,582 (+45.8%)13.4% CAGR

5Y$27,462+$17,462 (+174.6%)22.4% CAGR

10Y$19,926+$9,926 (+99.3%)7.1% CAGR

15Y$32,938+$22,938 (+229.4%)8.3% CAGR

20Y$10,126+$126 (+1.3%)0.1% CAGR

30Y$18,417+$8,417 (+84.2%)2.1% CAGR

Avadel Pharmaceuticals plc did not pay dividends during this period. Total return = price return.

Loading AVDL total return...

As of 2026-05-06

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+0.56%	—	+0.56%	—	$10,056
1Y	+150.46%	150.46%	+150.46%	—	$25,046
3Y	+45.82%	13.40%	+45.82%	—	$14,582
5Y	+174.62%	22.39%	+174.62%	—	$27,462
10Y	+99.26%	7.14%	+99.26%	—	$19,926
15Y	+229.38%	8.27%	+229.38%	—	$32,938
20Y	+1.26%	0.06%	+1.26%	—	$10,126
30Y	+84.17%	2.06%	+84.17%	—	$18,417

Risk & Highlights

Best Year+561.48%2003

Worst Year-75.47%1997

Max Drawdown-13.88%2025-06-10 → 2025-07-01 · Recovered 2025-07-15

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+0.56%	+0.56%	—	+0.41%	+0.1pp
2025	+95.91%	+95.91%	—	+16.64%	+79.3pp
2024	-26.40%	-26.40%	—	+24.00%	-50.4pp
2023	+101.71%	+101.71%	—	+24.81%	+76.9pp
2022	-13.63%	-13.63%	—	-19.95%	+6.3pp

AVDL outperformed the S&P 500 by 119.14pp over the past year (+150.46% vs +31.32%).

Loading summary...

AVDL Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
AVDLAvadel Pharmaceuticals plc	$2.1B	—	+0.6%	+150.5%	—	+45.8%	+174.6%	+99.3%
JAZZJazz Pharmaceuticals plc	$14.3B	+22.3%	+32.0%	+105.6%	—	+64.8%	+32.2%	+58.3%
AXSMAxsome Therapeutics, Inc.	$11.5B	+31.2%	+24.6%	+98.5%	—	+186.4%	+295.0%	+1858.0%
INVAInnoviva, Inc.	$1.9B	-2.2%	+13.3%	+20.4%	—	+92.8%	+95.5%	+90.5%
SUPNSupernus Pharmaceuticals, Inc.	$3.0B	+1.8%	+4.0%	+58.6%	—	+39.8%	+75.7%	+240.3%
PGNYProgyny, Inc.	$1.5B	+11.4%	-27.4%	-19.9%	—	-46.3%	-64.1%	+17.3%
NKTRNektar Therapeutics	$1.7B	+13.9%	+96.0%	+783.6%	—	+636.7%	-69.4%	-57.6%
COLLCollegium Pharmaceutical, Inc.	$1.2B	+12.0%	-19.8%	+35.1%	—	+55.9%	+66.4%	+141.8%
HALOHalozyme Therapeutics, Inc.	$7.8B	+5.2%	-5.6%	+11.7%	—	+119.1%	+39.1%	+598.4%
PRAXPraxis Precision Medicines, Inc.	$7.6B	+9.0%	+18.0%	+860.9%	—	+2005.6%	-18.4%	-19.0%
PTCTPTC Therapeutics, Inc.	$5.5B	-3.3%	-13.2%	+84.1%	—	+19.9%	+65.2%	+839.5%

Compare:AVDL vs JAZZ AVDL vs AXSM AVDL vs INVA AVDL vs JAZZ vs AXSM

About AVDL Dividend Returns

Avadel Pharmaceuticals plc (AVDL) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of AVDL over the past year?

Avadel Pharmaceuticals plc (AVDL) delivered a return of 150.46% over the past year. Since AVDL does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in AVDL be worth today?

A $10,000 investment in Avadel Pharmaceuticals plc one year ago would be worth $25,046 today, representing a gain of $15,046.

Q3Does AVDL pay dividends?

Avadel Pharmaceuticals plc (AVDL) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For AVDL, the total return equals the price-only return.

Q4Did AVDL beat the S&P 500?

Yes, Avadel Pharmaceuticals plc (AVDL) outperformed the S&P 500 by 119.14 percentage points over the past year. AVDL delivered a total return of 150.46%, compared to the S&P 500's 31.32%. This 119.14pp alpha means investors in AVDL earned more than a passive S&P 500 index fund.

Q5What is AVDL's worst drawdown?

Avadel Pharmaceuticals plc (AVDL) experienced a maximum drawdown of -13.88% over the past year, declining from its peak on 2025-06-10 to its trough on 2025-07-01. The stock recovered to its prior peak by 2025-07-15. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is AVDL's long-term total return over 10, 20, or 30 years?

Here are Avadel Pharmaceuticals plc (AVDL)'s long-term returns with dividends reinvested. Over 10 years, the total return is 99.3% (7.1% CAGR) — $10,000 would have grown to $19,926. Over 20 years: 1.3% total return (0.1% CAGR) — $10,000 → $10,126. Over 30 years: 84.2% total return (2.1% CAGR) — $10,000 → $18,417. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was AVDL's best and worst year?

Avadel Pharmaceuticals plc's best calendar year was 2003 with a total return of 561.5%. Its worst year was 1997 with a total return of -75.5%. This range shows the volatility investors should expect — the difference between the best and worst year is 637.0 percentage points.